Structures by: Maulik P. R.
Total: 61
C18H28O7
C18H28O7
Organic letters (2015) 17, 20 4948-4951
a=9.874(1)Å b=10.305(2)Å c=18.765(3)Å
α=90.00° β=99.09(1)° γ=90.00°
1,2,3-terphenylbenzene
C33H32N2O2
Organic letters (2008) 10, 12 2553-2556
a=10.822(1)Å b=23.126(3)Å c=11.615(1)Å
α=90.00° β=104.45(1)° γ=90.00°
Cyclophane
C18H20N8O2S2
Organic letters (2009) 11, 22 5290-5293
a=13.075(3)Å b=16.85(1)Å c=9.30(1)Å
α=90.00° β=90.00° γ=90.00°
4-[(2-tert-butoxymethyl-3-hydroxy-6-isopropoxy-3,6-dihydro-2H- pyran-4-yl)hydroxy-methyl]-benzonitrile
C22H29NO6
Journal of medicinal chemistry (2007) 50, 13 2942-2950
a=14.443(2)Å b=5.797(1)Å c=15.243(2)Å
α=90.00° β=115.40(1)° γ=90.00°
Annulated Coumarin
C21H14O2
Organic & biomolecular chemistry (2013) 11, 32 5239-5253
a=15.050(5)Å b=8.960(3)Å c=21.187(7)Å
α=90.00° β=90.00° γ=90.00°
Benzofuran
C12H6Cl2N4O2
Organic & biomolecular chemistry (2013) 11, 32 5239-5253
a=20.542(2)Å b=7.5120(10)Å c=18.182(2)Å
α=90.00° β=109.5930(10)° γ=90.00°
C31H31NO6
C31H31NO6
RSC Adv. (2014) 4, 17 8828
a=8.7579(8)Å b=10.0549(9)Å c=16.4135(15)Å
α=104.343(2)° β=94.619(2)° γ=106.200(2)°
((5R,7S)-7-isopropoxy-3-(4-nitrophenyl)-4-oxo-2-phenyl- 2,4,5,7-tetrahydropyrano(3,4-c)pyrazol-5-yl) methyl acetate
C24H23N3O7
RSC Advances (2013) 3, 14 4526
a=5.9798(9)Å b=14.147(2)Å c=25.909(4)Å
α=90.00° β=90.00° γ=90.00°
6'-benzoyl-7'-(4-chlorophenyl)-3'-phenyl-3',6',7',7a'- tetrahydro-1 'H-spiro(indoline-3,5'-pyrrolo(1,2-c)thiazol)-2-one
C32H25ClN2O2S
RSC Advances (2013) 3, 14 4731
a=10.428(5)Å b=16.883(5)Å c=17.610(5)Å
α=90.00° β=119.485(17)° γ=90.00°
Naphtho isoquinoline
C26H31N3
RSC Advances (2012) 2, 4 1299
a=10.952(2)Å b=11.7610(1)Å c=17.935(4)Å
α=90.00° β=105.090(1)° γ=90.00°
2-(2-(4,6-bis(methylthio)-1H-pyrazolo[3,4-d]pyrimidin-1-yl) ethyl)phthalazin-1(2H)-one
C17H16N6OS2
CrystEngComm (2012) 14, 2 383
a=16.708(2)Å b=15.732(2)Å c=14.4360(10)Å
α=90.00° β=107.790(10)° γ=90.00°
2-(2-(4-chloro-6-(methylthio)-1H-pyrazolo [3,4-d]pyrimidin-1-yl)ethyl)phthalazin-1(2H)-one
C16H13ClN6OS
CrystEngComm (2012) 14, 2 383
a=9.1610(10)Å b=14.0630(10)Å c=13.1090(10)Å
α=90.00° β=102.120(10)° γ=90.00°
None
C17H16N6O4S
CrystEngComm (2012) 14, 2 383
a=18.2274(5)Å b=15.2903(4)Å c=13.9319(5)Å
α=90.00° β=108.746(3)° γ=90.00°
None
C17H16N6O4S
CrystEngComm (2012) 14, 2 383
a=9.2490(10)Å b=17.580(2)Å c=11.550(2)Å
α=90.00° β=105.110(10)° γ=90.00°
None
C16H13ClN6O3S
CrystEngComm (2012) 14, 2 383
a=13.6729(8)Å b=9.0043(6)Å c=13.8349(8)Å
α=90.00° β=90.388(5)° γ=90.00°
5e
C25H26N6O5
RSC Adv. (2015) 5, 87 70958
a=5.8603(5)Å b=11.0162(13)Å c=19.371(2)Å
α=76.719(7)° β=87.487(6)° γ=80.980(6)°
(E)-methyl 2-(4-benzyl-1-(3-(dimethylamino)propyl)-8-nitro-3-oxo-3,4-dihydropyrazino[2,3-b]quinoxalin-2(1H)-ylidene)acetate
C16H15N5O3
RSC Adv. (2015) 5, 87 70958
a=8.4267(9)Å b=10.4362(12)Å c=17.949(2)Å
α=90° β=100.189(7)° γ=90°
C16H13NO2S
C16H13NO2S
Journal of the Chemical Society, Perkin Transactions 1 (2000) 22 3719
a=11.2827(10)Å b=13.2262(10)Å c=9.2390(10)Å
α=90.00° β=98.352(10)° γ=90.00°
3-cyano-6-(4-chlorophenyl)-4-[Bis(4-fluorophenyl)piperazino]-2H-pyran-2-one
C29H22ClF2N3O2
Journal of the Chemical Society, Perkin Transactions 1 (2001) 16 1953
a=44.292(4)Å b=7.6620(10)Å c=14.9490(10)Å
α=90.00° β=92.71° γ=90.00°
4-(4-chlorophenyl)-2-(2-pyridyl piperazino)-6-cyclopropyl benzonitrile
C25H23ClN4
Journal of the Chemical Society, Perkin Transactions 1 (2001) 16 1953
a=8.4520(10)Å b=12.3980(10)Å c=21.137(2)Å
α=75.020(10)° β=83.190(10)° γ=81.700(10)°
1,3-Bis(2,6-dimethyl sulfanyl-9H-purin-9-yl)-2-methylenyl propane
C18H20N8S4
CrystEngComm (2011) 13, 6 2039
a=16.357(3)Å b=10.062(2)Å c=13.506(3)Å
α=90.00° β=90.00° γ=90.00°
1,3-Bis(4,6-dimethyl sulfanyl-1H-pyrazolo(3,4-d) pyrimidin-1- yl)-2-methylenyl propane
C18H20N8S4
CrystEngComm (2011) 13, 6 2039
a=9.122(5)Å b=9.560(5)Å c=14.181(5)Å
α=102.828(5)° β=102.183(5)° γ=107.820(5)°
1-(9H-carbazol-9-yl)-3-(4-methoxy-6-methylsulfanyl-1H- pyrazolo (3,4-d)pyrimidin-1-yl)-2-methylenepropane
C23H21N5OS
CrystEngComm (2011) 13, 6 2039
a=8.5125(5)Å b=10.6289(7)Å c=11.9705(8)Å
α=70.965(3)° β=81.944(3)° γ=86.356(3)°
1-(9H-carbazol-9-yl)-3-(4,6-dimethylsulfanyl-1H-pyrazolo (3,4- d)pyrimidin-1-yl)-2-methylenepropane
C23H21N5S2
CrystEngComm (2011) 13, 6 2039
a=10.1518(10)Å b=8.7585(9)Å c=24.492(3)Å
α=90.00° β=101.961° γ=90.00°
Guggulsterone E
C21H28O2
Acta Crystallographica Section E (2001) 57, 3 o285-o286
a=7.4634(11)Å b=13.747(2)Å c=17.352(3)Å
α=90.00° β=94.862(12)° γ=90.00°
Pentaacetoxy taxadiene
C30H42O10,0.29H2O
Acta Crystallographica Section E (2002) 58, 2 o154-o155
a=11.252(2)Å b=16.003(3)Å c=16.801(2)Å
α=90.00° β=90.00° γ=90.00°
1,4-Dicholoro-1,4-diphenyl-2,3-diazabuta-1,3-diene
C14H10Cl2N2
Acta Crystallographica Section E (2002) 58, 8 o869-o870
a=11.5010(10)Å b=7.5319(7)Å c=14.958(2)Å
α=90.00° β=99.250(10)° γ=90.00°
Pyrazolo[3,4-d]pyrimidine
C18H22N8O2S2
Acta Crystallographica Section E (2002) 58, 8 o940-o941
a=7.4330(10)Å b=8.1170(10)Å c=9.6460(10)Å
α=71.430(10)° β=72.430(10)° γ=71.360(10)°
Neridienone A
C21H26O3
Acta Crystallographica Section E (2005) 61, 11 o3905-o3907
a=11.585(2)Å b=6.2420(10)Å c=12.313(2)Å
α=90.00° β=99.730(10)° γ=90.00°
Rearranged taxoid
C28H40O12
Acta Crystallographica Section E (2001) 57, 12 o1158-o1160
a=8.9570(10)Å b=9.6670(10)Å c=9.8270(10)Å
α=110.100(10)° β=92.420(10)° γ=110.390(10)°
1,3-bis(8-chlorotheophyllin-7-yl)propane
C17H18Cl2N8O4
Acta Crystallographica Section E (2001) 57, 12 o1163-o1165
a=19.9290(10)Å b=4.3417(2)Å c=22.788(2)Å
α=90.00° β=91.400(10)° γ=90.00°
Dioxypyrido[2,3-d]pyrimidine
C17H13BrN4O2
Acta Crystallographica Section E (2001) 57, 5 o408-o410
a=8.728(3)Å b=12.087(4)Å c=8.672(3)Å
α=108.22(3)° β=113.43(2)° γ=91.24(3)°
Thiazolidin-4-one
C15H18ClNOS
Acta Crystallographica Section E (2003) 59, 8 o1239-o1240
a=17.6000(10)Å b=9.7750(10)Å c=17.0890(10)Å
α=90.00° β=97.330(10)° γ=90.00°
C13H16N4O4S2
C13H16N4O4S2
Acta Crystallographica Section C (1996) 52, 10 2563-2566
a=7.529(4)Å b=20.689(12)Å c=30.469(16)Å
α=90° β=90° γ=90°
(pyrazolo[3,4-d]pyrimidin-1-yl)alkane
C17H20N8O2S2
Acta Crystallographica Section C (1998) 54, 2 275-277
a=13.459(4)Å b=9.2087(15)Å c=15.883(5)Å
α=90.00° β=98.87(4)° γ=90.00°
9,10-dihydrophenanthrene
C23H19ClO4
Acta Crystallographica Section C (1997) C53, 1713-1714
a=8.9047(7)Å b=9.6102(13)Å c=12.9962(15)Å
α=110.332(12)° β=104.167(8)° γ=97.458(8)°
C14-oxygenated taxoid
C31H46O8
Acta Crystallographica Section C (1999) 55, 3 IUC9900014
a=9.789(7)Å b=12.754(3)Å c=24.586(9)Å
α=90.00° β=90.00° γ=90.00°
C17H20N8S4
C17H20N8S4
Acta Crystallographica Section C (1995) 51, 11 2453-2455
a=9.397(6)Å b=9.627(8)Å c=13.805(8)Å
α=96.20(6)° β=102.31(5)° γ=115.17(6)°
C24H22O3
C24H22O3
Acta Crystallographica Section C (1998) 54, 1 134-136
a=10.236(2)Å b=10.258(2)Å c=18.827(4)Å
α=90.00° β=105.10(2)° γ=90.00°
Tetraazaphenalene
C13H16N4O2S2
Acta Crystallographica Section E (2006) 62, 11 o4991-o4993
a=10.155(2)Å b=10.261(2)Å c=14.382(3)Å
α=90.00° β=102.33(2)° γ=90.00°
Thiazolidinones
C18H12Cl2N2OS
Acta Crystallographica Section E (2006) 62, 12 o5349-o5351
a=13.7940(10)Å b=7.8680(10)Å c=16.299(2)Å
α=90.00° β=111.360(10)° γ=90.00°
Dysobinin
C30H38O6
Acta Crystallographica Section C (2000) 56, 6 e253-e254
a=12.426(3)Å b=29.446(10)Å c=7.450(9)Å
α=90.00° β=90.00° γ=90.00°
Pyrazolo[3,4-d]pyrimidine
C18H22N8O2S2
Acta Crystallographica Section C (2000) 56, 11 1361-1363
a=31.736(7)Å b=8.308(2)Å c=17.467(4)Å
α=90.00° β=115.12(2)° γ=90.00°
Pyrazolo[1,5-a]pyridine
C26H17BrFeN4
Acta Crystallographica Section C (2000) 56, 3 e88-e89
a=7.96080(10)Å b=10.68440(10)Å c=12.8215(3)Å
α=93.5770(10)° β=97.7370(10)° γ=99.0460(10)°
Pyrazolo[3,4-d]pyrimidine
C29H28N8O2S2
Acta Crystallographica Section C (2002) 58, 8 o494-o495
a=9.1500(10)Å b=9.4910(10)Å c=16.839(2)Å
α=83.010(10)° β=85.260(10)° γ=76.390(10)°
Pyrazolo[3,4-d]pyrimidine
C22H29N9S3
Acta Crystallographica Section C (2003) 59, 1 o42-o45
a=10.1195(8)Å b=11.8650(10)Å c=12.2710(10)Å
α=70.563(7)° β=70.092(8)° γ=73.452(7)°
Pyrazolo[3,4-d]pyrimidine
C25H34N10S2
Acta Crystallographica Section C (2003) 59, 1 o42-o45
a=10.0060(10)Å b=15.2830(10)Å c=18.411(2)Å
α=74.164(7)° β=89.970(9)° γ=86.359(9)°
Pyrazolo[3,4-d]pyrimidine
C18H17N5O2S2
Acta Crystallographica Section C (2003) 59, 8 o409-o412
a=10.4710(10)Å b=13.1323(11)Å c=14.0516(12)Å
α=90.00° β=102.190(10)° γ=90.00°
Parazolo[3,4-d]pyrimidine
C21H22N6O2S
Acta Crystallographica Section C (2003) 59, 8 o409-o412
a=7.5993(6)Å b=9.3968(7)Å c=15.376(2)Å
α=80.684(8)° β=82.480(10)° γ=72.685(6)°
Pyrazolo[3,4-d]pyrimidine
C17H20N4OS2
Acta Crystallographica Section C (2003) 59, 9 o494-o495
a=17.9660(10)Å b=10.0890(10)Å c=10.0550(10)Å
α=90.00° β=104.970(10)° γ=90.00°
Pyrazolo[3,4-d]pyrimidine
C25H36N8S4
Acta Crystallographica Section C (2003) 59, 9 o523-o524
a=21.044(2)Å b=8.8140(10)Å c=18.953(2)Å
α=90.00° β=118.070(10)° γ=90.00°
Pyrazolo[3,4-d]pyrimidin
C19H24N8O2S2
Acta Crystallographica Section C (2001) 57, 11 1324-1325
a=31.385(2)Å b=9.1290(10)Å c=16.8400(10)Å
α=90° β=115.52° γ=90°
Cinnamoyl shikonin
C25H22O6
Acta Crystallographica Section C (2001) 57, 10 1199-1200
a=6.16770(10)Å b=15.7416(3)Å c=10.5141(2)Å
α=90° β=90.7630(10)° γ=90°
4-Oxo-4,5-dihydropyrazolo[3,4-d]pyrimidine
C15H16N4OS
Acta Crystallographica Section C (2002) 58, 6 o325-o327
a=9.4742(8)Å b=19.2870(10)Å c=33.032(2)Å
α=90° β=90° γ=90°
Pyrazolo[3,4-d]pyrimidine
C14H14N4O2
Acta Crystallographica Section C (2002) 58, 6 o311-o313
a=7.4760(10)Å b=8.9230(10)Å c=10.1550(10)Å
α=76.680(10)° β=89.080(10)° γ=80.660(10)°
Pyrazolo[3,4-d]pyrimidine
C14H14N4O2
Acta Crystallographica Section C (2002) 58, 6 o311-o313
a=12.4680(10)Å b=7.4490(10)Å c=15.076(2)Å
α=90.00° β=108.940(10)° γ=90.00°
3,4,5-triaryl-benzonitrile
C34H29NO3S
The Journal of organic chemistry (2016) 81, 22 10721-10732
a=8.8040(10)Å b=21.251(4)Å c=17.142(4)Å
α=90.00° β=117.382(11)° γ=90.00°
Biphenyl
C14H12O2S
Journal of Organic Chemistry (2006) 71, 804-807
a=7.2150(10)Å b=11.2340(10)Å c=14.4730(10)Å
α=84.090(10)° β=88.610(10)° γ=87.870(10)°
1,3-Bis(9H-carbazol-9-yl)-2-methylenepropane
C28H22N2
CrystEngComm (2011) 13, 6 2039
a=9.3786(17)Å b=23.547(4)Å c=18.543(3)Å
α=90.00° β=90.617(3)° γ=90.00°
Pyrazolo[3,4-d]pyrimidine
C17H20N8S4
Acta Crystallographica Section C (2000) 56, 11 1361-1363
a=7.620(2)Å b=10.411(2)Å c=26.813(5)Å
α=90.00° β=97.92(2)° γ=90.00°
C30H42.58O10.29
C30H42.58O10.29
Acta Crystallographica Section E (2002) 58, 2 o154-o155
a=11.252(2)Å b=16.003(3)Å c=16.801(2)Å
α=90° β=90° γ=90°